Single or combined immune checkpoint inhibitors compared to first‐line chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
对于晚期非小细胞肺癌患者,单药或联合免疫检查点抑制剂与一线化疗(无论是否联合贝伐单抗)相比的疗效
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0249325
Sakyi, Samuel Asamoah; Laing, Edwin Ferguson; Mantey, Richard; Kwarteng, Alexander; Owiredu, Eddie-Williams; Dadzie, Richard Ephraim; Amoani, Benjamin; Opoku, Stephen; Afranie, Bright Oppong; Boakye, Daniel; Ferrara, Roberto; Imbimbo, Martina; Paget‐Bailly, Sophie; Malouf, Reem; Calais, François; Agazzi, Giorgio Maria; Marchal, Corynne; Westeel, Virginie